Cardio Diagnostics
CDIO
11 hedge funds and large institutions have $249K invested in Cardio Diagnostics in 2022 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 29 closing their positions.
61.81% less ownership
Funds ownership: 64.21% → 2.4% (-62%)
69% less funds holding
Funds holding: 35 → 11 (-24)
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
83% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 29
100% less capital invested
Capital invested by funds: $52.4M → $249K (-$52.2M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LA
Linden Advisors
New York
|
+$309K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$85.1K |
| 3 |
BFM
Boothbay Fund Management
New York
|
+$48.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$3.24K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$108 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$5.6M |
| 2 |
SCM
Saba Capital Management
New York
|
-$4.73M |
| 3 |
KIM
Karpus Investment Management
Pittsford,
New York
|
-$4.6M |
| 4 |
Barclays
London,
United Kingdom
|
-$2.61M |
| 5 |
OCAM
Owl Creek Asset Management
New York
|
-$2.51M |
CDIO Hedge Fund Activity: Q4 2022 in Review
11 of the 6,239 institutional investors tracked by Wall St. Rank reported a position in Cardio Diagnostics (CDIO) for Q4 2022, worth a combined $249K — down 100% from $52.4M a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of CDIO and 5 opened new positions — a net loss of 24 holders — while 5 trimmed existing stakes and 1 added.
The largest buyer was Linden Advisors, opening a new position worth an estimated $309K. The largest seller was Periscope Capital, exiting entirely with an estimated $5.6M sold.
- 11 institutional investors held Cardio Diagnostics (CDIO) as of Q4 2022, down from 35 in Q3 2022.
- Funds reported $249K of Cardio Diagnostics stock for Q4 2022, down 100% quarter-over-quarter.
- 5 funds opened new Cardio Diagnostics positions in Q4 2022 and 29 closed out, a net change of -24 holders.
- The largest Cardio Diagnostics buyer in Q4 2022 was Linden Advisors, an estimated $309K added.
- The largest Cardio Diagnostics seller in Q4 2022 was Periscope Capital, an estimated $5.6M sold.
Based on aggregated 13F filings for Q4 2022.